APTAPHARMA INC FDA Approval ANDA 213041

ANDA 213041

APTAPHARMA INC

FDA Drug Application

Application #213041

Application Sponsors

ANDA 213041APTAPHARMA INC

Marketing Status

Prescription001

Application Products

001FOR SUSPENSION;ORALEQ 10MG BASE/ML0SILDENAFIL CITRATESILDENAFIL CITRATE

FDA Submissions

UNKNOWN; ORIG1AP2020-08-06STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

APTAPHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213041
            [companyName] => APTAPHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"SILDENAFIL CITRATE","activeIngredients":"SILDENAFIL CITRATE","strength":"EQ 10MG BASE\/ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/06\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"08\/06\/2020","submission":"SUPPL-1","supplementCategories":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-08-06
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.